Evaluation and optimization of factors affecting novel diclofenac sodium-eudragit RS100 nanoparticles

Khosro Adibkia; Mahmood Alaei-Beirami; Mohammad Barzegar-Jalali; Gobad Mohammadi; Mehdi Shafiee Ardestani

doi:10.5897/AJPP12.025

African Journal of
Pharmacy and Pharmacology

Abbreviation: Afr. J. Pharm. Pharmacol.
Language: English
ISSN: 1996-0816
DOI: 10.5897/AJPP
Start Year: 2007
Published Articles: 2286

Full Length Research Paper

Evaluation and optimization of factors affecting novel diclofenac sodium-eudragit RS100 nanoparticles

Khosro Adibkia1,2, Mahmood Alaei-Beirami2*, Mohammad Barzegar-Jalali1, Gobad Mohammadi3 and Mehdi Shafiee Ardestani4

1Biotechnology Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran. 2Drug Applied Research Center and Students’ Research Committee, Tabriz University of Medical Science, Tabriz, Iran. 3School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran. 4R&D & QC & Hepatitis B and Nanobiotechnology Department, Research an\, d Production Complex, Pasteur Institute of Iran, Tehran, Iran.
Email: [email protected]

Article Number - 5CC5B4E35354
Vol.6(12), pp. 941 - 947 , March 2012
https://doi.org/10.5897/AJPP12.025

Accepted: 06 March 2012
Published: 29 March 2012

Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0.